Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Lilly's experimental weight-loss drug may be a ‘multibillion-dollar opportunity'
12:17pm, Friday, 29'th Apr 2022
Eli Lilly & Co. Inc.'s LLY, -1.46% promising new weight-loss drug is taking aim at a sector that's littered with once-promising therapies that have failed to deliver on their promise to help people lo
Jim Cramer reacts to Roku, Eli Lilly, Tesla, and more
11:38am, Friday, 29'th Apr 2022
CNBC's Jim Cramer and the ‘Squawk on the Street' team break down shares of Roku, Eli Lilly, Tesla and more following a slew of earnings report from Big Tech companies.
Eli Lilly and Company's (LLY) CEO Dave Ricks on Q1 2022 Results - Earnings Call Transcript
04:21pm, Thursday, 28'th Apr 2022
Eli Lilly and Company (NYSE:LLY ) Q1 2022 Earnings Conference Call April 28, 2022 9:00 AM ET Company Participants Kevin Hern - Vice President, Investor Relations Dave Ricks - Chair and CEO Anat Ashken
Lilly's Tirzepatide Shows Up To 22.5% Weight Loss In New Phase 3 Readout
03:27pm, Thursday, 28'th Apr 2022
Eli Lilly And Co (NYSE: LLY) reported topline results from SURMOUNT-1 Phase 3 trial evaluating Tirzepatide (5 mg, 10 mg, 15 mg) in obese patients with at least one comorbidity who do not have diabe
GDP Declined in First Quarter
12:47pm, Thursday, 28'th Apr 2022
GDP Declined in First Quarter
Eli Lilly (LLY) Beats on Q1 Earnings, Ups Sales View, Stock Rises
12:47pm, Thursday, 28'th Apr 2022
Eli Lilly (LLY) beats first-quarter estimates for both earnings and sales and ups its sales outlook for 2022. The stock rises in pre-market trading.
Q1 GDP Negative; Q1 Earnings Beats from CAT, LLY, MCD
12:04pm, Thursday, 28'th Apr 2022
GDP reported the first negative quarter since Q2 2020, which was considered the "heart" of the pandemic.
Eli Lilly Q1 results: ‘Russia isn't a big part of our portfolio'
11:33am, Thursday, 28'th Apr 2022
Shares of Eli Lilly & Co (NYSE: LLY) opened 3.5% up on Thursday after the pharmaceutical company reported market-beating results for its fiscal first quarter on strong COVID-19 antibodies sales. Eli L
Eli Lilly (LLY) Q1 Earnings and Revenues Top Estimates
09:02am, Thursday, 28'th Apr 2022
Lilly (LLY) delivered earnings and revenue surprises of 12.93% and 3.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Eli Lilly drug tirzepatide meets weight-loss goals in obesity trial
07:08am, Thursday, 28'th Apr 2022
A highly anticipated clinical trial from Eli Lilly showed its Type 2 diabetes drug met its primary endpoints. CNBC's Meg Tirrell joins 'Squawk Box' to break down the results.
Eli Lilly stock rallies after earnings beat expectations, as COVID-19 antibodies revenue jumps 81%
06:45am, Thursday, 28'th Apr 2022
Shares of Eli Lilly & Co. LLY, +0.80% rallied 1.8% in premarket trading Thursday after the drug maker reported first-quarter profit and revenue that beat expectations, as better-than-forecast COVID-19
Drugmaker Eli Lilly reports near 40% jump in quarterly profit
06:36am, Thursday, 28'th Apr 2022
Drugmaker Eli Lilly and Co reported a near 40% rise in quarterly profit on Thursday, helped by strong demand for its top-selling diabetes drug and newer cancer treatments.
Eli Lilly Beats Estimates and the Stock Rises on Revenue Guidance Boost
06:34am, Thursday, 28'th Apr 2022
Eli Lilly raises its sales forecast for 2022 to $28.8 billion to $29.3 billion.
Drug/Biotech Stocks Q1 Earnings Due on Apr 28: MRK, LLY & More
03:18pm, Wednesday, 27'th Apr 2022
Let us look at the five biotech/pharma companies, slated to release quarterly results on Apr 28.
Does Eli Lilly's Future Depend on its Alzheimer's Drug?
08:11am, Saturday, 23'rd Apr 2022
Medicare's decision raises uncertainty about a key upcoming treatment.
